US 7232887
Melanoma antigens and their use in diagnostic and therapeutic methods
granted A61KA61K2039/5256A61K2039/53
Quick answer
US patent 7232887 (Melanoma antigens and their use in diagnostic and therapeutic methods) held by THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services expires Mon Jun 14 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jun 19 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 14 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/5256, A61K2039/53, A61K2239/31, A61K2239/38